Greater fracture risk with zolpidem than alprazolam or lorazepam in the elderly.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 4
- Publication type:
- Article
Works matching IS 10685308 AND DT 2012 AND VI 23 AND IP 1
Results: 10
1
2
Clinical guidance for long-term T3 augmentation in major depression.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 3
- Publication type:
- Article
3
EPA supplements for depression.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 7
- Publication type:
- Article
4
Slowing AD progression with memantine.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 7
- Publication type:
- Article
5
Commentary on the Comer et al. study.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 5
- By:
- Publication type:
- Article
6
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 8
- Publication type:
- Article
7
CASE REPORT. Risperidone and decompensation in a previously stable patient.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
8
Warfarin and antidepressants.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 2
- By:
- Publication type:
- Article
9
Low-dose antipsychotics generally safe in patients with intellectual disability, but caution still advised.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 1
- Publication type:
- Article
10
Increasing off-label use of antipsychotics for treating anxiety disorders.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 1
- Publication type:
- Article